Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium.
about
Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxiaThe protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis.Effects of sildenafil on the gastrocnemius and cardiac muscles of rats in a model of prolonged moderate exercise training.Impact of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels in Sildenafil-Induced Cardioprotection in Rats.Perspectives on: SGP symposium on mitochondrial physiology and medicine: mitochondrial proteome design: from molecular identity to pathophysiological regulation.Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells.Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.Impact of acellular hemoglobin-based oxygen carriers on brain apoptosis in rats.Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia.Cardioprotection by Intermittent Hypoxia Conditioning: Evidence, Mechanisms and Therapeutic Potential.
P2860
Q28534096-C2D71426-9656-46FC-81F9-FF5CCB195F90Q34676754-DD3E6AD0-803C-43A5-B089-49E217015D89Q34905015-93E9A0BF-85FF-4A72-B54B-AF7C47326688Q35869812-E1D45725-DA9B-4112-9CE4-CED28F4EBEC9Q35995732-AC9D4B76-569D-45EB-9ABC-995601F74562Q36128551-5E173515-60F3-43C6-ACF2-4C22B5644846Q37747432-0F82B9E7-50E4-422C-BB44-0A323A2ED4F4Q38542767-B8CA94E8-8E97-4EC4-97F3-887179D4D528Q39290264-21518F99-5052-40DB-B8FC-E1AFA836175BQ46734454-F3E718D4-9A33-4EBE-8C4F-853C68413651Q52325761-DCD2D04E-70B0-44E7-AADB-60ACDE76AE7EQ53695762-2E1BF9A8-EE88-421C-9275-8D781D9BE11D
P2860
Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@ast
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@en
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@nl
type
label
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@ast
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@en
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@nl
prefLabel
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@ast
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@en
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@nl
P2093
P2860
P50
P1433
P1476
Phosphodiesterase-5 inhibition ...... ion in the hypoxic myocardium.
@en
P2093
Antonio F Corno
Giuseppe Vassalli
Ludwig K von Segesser
Paola Bianciardi
Viviane Rochemont
P2860
P304
P356
10.1371/JOURNAL.PONE.0027910
P407
P577
2011-11-28T00:00:00Z